Castle Biosciences, Inc. Common Stock (NASDAQ: CSTL) last traded at $34.20, up 3.86% on the session. The quote above updates while this page is open; the figures below are drawn from Castle Biosciences, Inc. Common Stock’s own filings and are restated only when a new one is published.
Castle Biosciences, Inc. Common Stock trades on NASDAQ under the ticker CSTL. Its market capitalisation is $1.04 billion.
Valuation measures for Castle Biosciences, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.04B |
|---|---|
| Enterprise value | $1.07B |
| Price / sales | 2.92 |
| Price / book | 2.22 |
| Beta | 0.91 |
Trailing-twelve-month figures tagged in Castle Biosciences, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $357.28M |
|---|---|
| Net income (TTM) | -$19.41M |
| EPS (TTM) | -$0.640 |
| Operating margin | -8.99% |
| Return on equity | -4.13% |
| Cash | $62.12M |
Range and volume for CSTL over the past 52 weeks.
| 52-week high | $44.28 |
|---|---|
| 52-week low | $17.72 |
| Volume | 573.5K |
| Average volume | 403.4K |
| Previous close | $32.93 |
Dividend history for Castle Biosciences, Inc. Common Stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.